Denise Patton
Nurse Practitioner · Hot Springs, ARNPI 1588014294
Payments from drug & device makers
Across 17 payments — averaging $21.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$65
- Myovant Sciences Inc.$57
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$56
- Otsuka America Pharmaceutical, Inc.$43
- Boston Scientific$28
- AbbVie$27
- plus $97 from 5 others
What the payments were for
- Food & beverage$30883%
- Education$6517%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 1 | $65 |
| Myovant Sciences Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Boston Scientific | 1 | $28 |
| AbbVie | 2 | $27 |
| Lilly USA, LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $15 |
How this compares
$373 in reported general payments places this provider in the 60th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ezetimibe | 24 | $828 |
| Ventolin HfaAlbuterol Sulfate | 12 | $674 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $362 |
| Venlafaxine Hcl | 15 | $351 |
| Doxycycline Hyclate | 31 | $296 |
| Atorvastatin Calcium | 43 | $285 |
| Omeprazole | 24 | $283 |
| Gabapentin | 23 | $280 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $268 |
| Levothyroxine Sodium | 30 | $248 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $228 |
| Amlodipine Besylate | 57 | $201 |
| Tizanidine Hcl | 20 | $178 |
| Ondansetron OdtOndansetron | 15 | $174 |
| Tramadol Hcl | 27 | $152 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Hot Springs
- Tiffany McConathyHot Springs$54K
- Virginia LaliberteHot Springs$21K
- Samantha WidemanHot Springs$14K
- Cody WilliamsHot Springs$12K
- Nan MeansHot Springs$7K
- Ragan ArrisonHot Springs$7K
- Laci PattonHot Springs$7K
- Samantha BollanHot Springs$7K
- Kayla HarringtonHot Springs$6K
- Mindy FarmerHot Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.